Literature DB >> 19406006

Silymarin inhibits melanin synthesis in melanocyte cells.

Soo-Jin Choo1, In-Ja Ryoo, Young-Hee Kim, Guang-Hwa Xu, Won-Gon Kim, Ki-Ho Kim, Seong-Joon Moon, Eui-Dong Son, KiHwan Bae, Ick-Dong Yoo.   

Abstract

OBJECTIVES: The aim was to search for inhibitors of melanogenesis from natural resources.
METHODS: The inhibitory effect of silymarin on melanogenesis in a spontaneously immortalized mouse melanocyte cell line, Mel-Ab, was studied. KEY
FINDINGS: Silymarin significantly prevented melanin production in a dose-dependent manner with an IC50 value (concentration producing 50% maximal inhibition) of 28.2 microg/ml, without effects on cell viability. Also, silymarin inhibited L-DOPA oxidation activity of tyrosinase, the rate-limiting melanogenic enzyme, in cell based-systems but it did not directly affect cell-free tyrosinase activity. Furthermore, Western blot analysis indicated that silymarin decreased the expression of tyrosinase protein.
CONCLUSIONS: This study suggests that the depigmenting effect of silymarin might be attributable to inhibition of tyrosinase expression and that silymarin may be useful as a natural skin-lightening agent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406006     DOI: 10.1211/jpp/61.05.0016

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Formulation of microemulsion systems for dermal delivery of silymarin.

Authors:  Vipaporn Panapisal; Sawitree Charoensri; Angkana Tantituvanont
Journal:  AAPS PharmSciTech       Date:  2012-02-16       Impact factor: 3.246

Review 2.  Implications of Oxidative Stress in the Pathogenesis and Treatment of Hyperpigmentation Disorders.

Authors:  Xiaoxue Xing; Yanjun Dan; Zhongyi Xu; Leihong Xiang
Journal:  Oxid Med Cell Longev       Date:  2022-01-18       Impact factor: 6.543

3.  Diarylpropionitrile inhibits melanogenesis via protein kinase A/cAMP-response element-binding protein/microphthalmia-associated transcription factor signaling pathway in α-MSH-stimulated B16F10 melanoma cells.

Authors:  Hyun Jeong Lee; Sungkwan An; Seunghee Bae; Jae Ho Lee
Journal:  Korean J Physiol Pharmacol       Date:  2022-03-01       Impact factor: 2.016

4.  The treatment of melasma by silymarin cream.

Authors:  Tagreed Altaei
Journal:  BMC Dermatol       Date:  2012-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.